Zhou, Elaine

Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis

Zhang, T., Pang, C., Li, N., Zhou, E., & Zhao, K. (2013) · BMC Medicine

Retinal Diseases and TreatmentsBlood Coagulation and Thrombosis Mechanisms

Cited by 270

FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment Trial

Nti, A. A., Serrano, L. W., Sandhu, H. S., Uyhazi, K. E., Edelstein, I. D., Zhou, E. J., Bowman, S., Song, D., Gangadhar, T. C., Schuchter, L. M., et al. (2019) · Retina

Drug-Induced Ocular ToxicityOcular Oncology and Treatments

Cited by 31

Effect of stimulants on final adult height

Wojnowski, N. M., Zhou, E., & Jee, Y. H. (2022) · Journal of Pediatric Endocrinology and Metabolism

Attention Deficit Hyperactivity DisorderGrowth Hormone and Insulin-like Growth Factors

Cited by 6